Cited by CrossRef (31)
- Lynn Chin, Chantelle Ye Gwen Wong, Harinder Gill. Targeting and Monitoring Acute Myeloid Leukaemia with Nucleophosmin-1 (NPM1) Mutation. IJMS 2023;24:3161
- Guadalupe Rosario Fajardo-Orduña, Edgar Ledesma-Martínez, Itzen Aguiñiga-Sánchez, María de Lourdes Mora-García, Benny Weiss-Steider, Edelmiro Santiago-Osorio. Inhibitors of Chemoresistance Pathways in Combination with Ara-C to Overcome Multidrug Resistance in AML. A Mini Review. IJMS 2021;22:4955
- Yáiza Núñez, Annabel Garcia-León, Aïda Falgàs, Naroa Serna, Laura Sánchez-García, Ana Garrido, Jorge Sierra, Alberto Gallardo, Ugutz Unzueta, Esther Vázquez, Antonio Villaverde, Ramon Mangues, Isolda Casanova. T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo. Pharmaceutics 2023;15:727
- Mustafa A. Bashi, Ali H. Ad'hiah. Molecular landscape of the interleukin-40 encoding gene, C17orf99, in patients with acute myeloid leukemia. Gene 2024;904:148214
- Hong Liu, Yuye Shi, Shandong Tao, Yunjie Li, Chunling Wang, Liang Yu.
Clinical and molecular characteristics of acute myeloid leukemia and the dismal prognosis of
TP53
mutations in a real-world setting
. Hematology 2023;28
- Seo-Yeon Ahn, TaeHyung Kim, Mihee Kim, Ga-Young Song, Sung-Hoon Jung, Deok-Hwan Yang, Je-Jung Lee, Mi Yeon Kim, Chul Won Jung, Jun-Ho Jang, Hee Je Kim, Joon Ho Moon, Sang Kyun Sohn, Jong-Ho Won, Sung-Hyun Kim, Hyeoung-Joon Kim, Jae-Sook Ahn, Dennis Dong Hwan Kim. Clinical Significance of bZIP In-Frame CEBPA-Mutated Normal Karyotype Acute Myeloid Leukemia. Cancer Res Treat 2023;55:1011
- Maria M. Aivalioti, Boris A. Bartholdy, Kith Pradhan, Tushar D. Bhagat, Aliona Zintiridou, Jong Jin Jeong, Victor J. Thiruthuvanathan, Mario Pujato, Aditi Paranjpe, Chi Zhang, Ross L. Levine, Aaron D. Viny, Amittha Wickrema, Amit Verma, Britta Will. PU.1-Dependent Enhancer Inhibition Separates Tet2-Deficient Hematopoiesis from Malignant Transformation. 2022;3:444
- Zhijie Wang, Jiongheng Cai, Jiwei Ren, Yun Chen, Yingli Wu, Jie Cheng, Kun Jia, Fei Huang, Zitian Cheng, Tiancheng Sheng, Shiyu Song, Hao Heng, Yifan Zhu, Weifang Tang, Hongmei Li, Tao Lu, Yadong Chen, Shuai Lu. Discovery of a Potent FLT3 Inhibitor (LT-850-166) with the Capacity of Overcoming a Variety of FLT3 Mutations. J. Med. Chem. 2021;64:14664
- Hee Sue Park. What is new in acute myeloid leukemia classification?. Blood Res. 2024;59
- Masumeh Maleki Behzad, Mohammad Abbasi, Iman Oliaei, Somayeh Ghorbani Gholiabad, Hassan Rafieemehr. Effects of Lifestyle and Environmental Factors on the Risk of Acute Myeloid Leukemia: Result of a Hospital-based Case-Control Study. J Res Health Sci 2021;21:e00525
- Mihee Kim, TaeHyung Kim, Seo-Yeon Ahn, Jun Hyung Lee, Ju Heon Park, Myung-Geun Shin, Sung-Hoon Jung, Ga-Young Song, Deok-Hwan Yang, Je-Jung Lee, Seung Hyun Choi, Mi Yeon Kim, Jae-Sook Ahn, Hyeoung-Joon Kim, Dennis Dong Hwan Kim. The prognostic impact of reduced variant burden in elderly patients with acute myeloid leukemia treated with decitabine. Korean J Intern Med 2023;38:534
- Rohit Kumar, Sapna Ratan Shah, Thomas Stiehl. Understanding the impact of feedback regulations on blood cell production and leukemia dynamics using model analysis and simulation of clinically relevant scenarios. Applied Mathematical Modelling 2024;129:340
- Dade Rong, Xiaomin Chen, Jing Xiao, Daiyuan Liu, Xiangna Ni, Xiuzhen Tong, Haihe Wang. Histone methylation modification patterns and relevant M-RiskScore in acute myeloid leukemia. Heliyon 2022;8:e10610
- Enjun Kong, Yan Xu, Hong Jin, Tahani Awad Alahmadi, Samer Hasan Hussein Al Ali. Modulations by L-Carvone and Thymoquinone to Exert Protection on Bone Marrow Cells Against Benzene-induced Toxicities Through Anti-inflammatory Pathways in SD Rats. Pharmacognosy Magazine 2024;20:280
- Paulina Stefaniuk, Agnieszka Szymczyk, Monika Podhorecka. In Pursuit of Genetic Prognostic Factors and Treatment Approaches in Secondary Acute Myeloid Leukemia—A Narrative Review of Current Knowledge. JCM 2022;11:4283
- Kai J. Rogers, Ibrahim M. Abukhiran, Sergei Syrbu, Michael Tomasson, Melissa Bates, Prajwal Dhakal, Sharathkumar Bhagavathi. Utilizing digital pathology and immunohistochemistry of p53 as an adjunct to molecular testing in myeloid disorders. Academic Pathology 2023;10:100064
- Suzana Tesanovic, Peter W. Krenn, Fritz Aberger. Hedgehog/GLI signaling in hematopoietic development and acute myeloid leukemia—From bench to bedside. Front. Cell Dev. Biol. 2022;10
- Shih-Chia Yeh, Faith J. F. Cheong, Yvonne Tay. Circular RNAs and Untranslated Regions in Acute Myeloid Leukemia. IJMS 2023;24:3215
- Huai-Hsuan Huang, Chieh-Min Chen, Chen-Yu Wang, William Wei-Yuan Hsu, Ho-Min Chen, Bor-Sheng Ko, Fei-Yuan Hsiao, Mohamed A. Yassin. The epidemiology, treatment patterns, healthcare utilizations and costs of Acute Myeloid Leukaemia (AML) in Taiwan. PLoS ONE 2022;17:e0261871
- Hui Han, Baofang Zhu, Jinye Xie, Yunxiu Huang, Yiyun Geng, Kang Chen, Weijia Wang. Expression level and prognostic potential of beta-catenin–interacting protein in acute myeloid leukemia. 2022;101:e30022
- Pedro Casado, Pedro R. Cutillas. Proteomic Characterization of Acute Myeloid Leukemia for Precision Medicine. Molecular & Cellular Proteomics 2023;22:100517
- Rafał Skopek, Małgorzata Palusińska, Katarzyna Kaczor-Keller, Rafał Pingwara, Anna Papierniak-Wyglądała, Tino Schenk, Sławomir Lewicki, Artur Zelent, Łukasz Szymański. Choosing the Right Cell Line for Acute Myeloid Leukemia (AML) Research. IJMS 2023;24:5377
- Sarah Noor, Ahmed Maseh Haidary, Ahmad Walid Yosufzai, Mirajan Niazai, Sahar Noor, Najla Nasir, Ayub Shinwari, Ramin Saadaat. Demographic and clinical characteristics of acute myeloid leukaemia diagnosed and treated at the tertiary level in Afghanistan. Br J Haematol 2023;203:404
- Dania Vázquez-Blomquist, Ailyn C. Ramón, Mauro Rosales, George V. Pérez, Ailenis Rosales, Daniel Palenzuela, Yasser Perera, Silvio E. Perea. Gene expression profiling unveils the temporal dynamics of CIGB-300-regulated transcriptome in AML cell lines. BMC Genomics 2023;24
- Maryam Farzaneh, Sajad Najafi, Mohadeseh Sheykhi-Sabzehpoush, Fereshteh Nezhad Dehbashi, Omid Anbiyaee, Ava Nasrolahi, Shirin Azizidoost. The stem cell-specific long non-coding RNAs in leukemia. Clin Transl Oncol 2022;25:345
- Mustafa A. Bashi, Ali H. Ad'hiah. Interleukin-37 gene expression is down-regulated in patients with acute myeloid leukemia and shown to be affected by CD14 and HLA-DR immunophenotypes. Cytokine 2023;171:156368
- Wonhyoung Seo, Prashanta Silwal, Ik-Chan Song, Eun-Kyeong Jo. The dual role of autophagy in acute myeloid leukemia. J Hematol Oncol 2022;15
- Niloufar Saber-Moghaddam, Mohammad Moeini Nodeh, Vahid Ghavami, Hossein Rahimi, Sajjad Ataei Azimi, Mohsen Seddigh-Shamsi, Mostafa Kamandi, Abolghasem Allahyari, Somayeh Sadat Shariatmaghani, Sepideh Elyasi, Omid Arasteh. The evaluation of atorvastatin as an adjunct to fluconazole for the anti-fungal prophylaxis in acute myeloid leukemia: a multicenter, triple-blinded, randomized clinical trial. Naunyn-Schmiedeberg's Arch Pharmacol 2023
- Teresa Gravina, Chiara Maria Teresa Boggio, Elisa Gorla, Luisa Racca, Silvia Polidoro, Sara Centonze, Daniela Ferrante, Monia Lunghi, Andrea Graziani, Davide Corà, Gianluca Baldanzi. Role of Diacylglycerol Kinases in Acute Myeloid Leukemia. Biomedicines 2023;11:1877
- Shahzeb Saeed, Raghu Halappa Nagaraj, Han Grezenko, Abdur Rehman, Abdullah Shehryar, Mohammad Ahsan Anwaar, Slobodan Lazarevic, S. M. Iram Shahzed, Archana Das, Karla I Vargas . FLT3-ITD Mutation and Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia: A Case Study. 2023
- Mouna Korbi, Jacem Rouatbi, Dorra Belloumi, Asma Hermassi, Badreddine Sriha, Ghada Sahraoui, Thabet Ben Othmen, Jameleddine Zili. Cutaneous granulocytic sarcoma arising on a surgical scar. IJDVL 2023;89:735